L&K Biomed Holds "Pectus Cadaver Workshop" at Cleveland Clinic in the U.S. View original image

On March 27, L&K Biomed announced that its U.S. subsidiary, Aegis Meditech, INC, successfully held the "Pectus Cadaver Workshop" at the Cleveland Clinic on March 24 (local time).


This workshop was exclusively sponsored by Aegis Meditech and was organized to enhance the anatomical understanding of healthcare professionals in the field of chest wall deformity surgery. Approximately 20 pediatric and thoracic surgeons from North America participated in the event. The Cleveland Clinic consistently ranks among the top U.S. hospitals and is known worldwide as a premier institution where medical professionals from around the globe receive training.


The workshop brought together healthcare professionals who are already using, or considering the adoption of, L&K Biomed's pectus excavatum implant, "Pectus," to share real clinical cases and surgical experiences. In addition, the "Pre-Twisted Bar" from the Pectus product line was introduced, presenting a new option to enhance the efficiency of chest wall deformity correction surgeries.


The "Pre-Twisted Bar" is a product jointly developed with the Cleveland Clinic. It is designed to address the inconvenience of manually twisting the ends of the bar inside the body during traditional surgical procedures. By pre-twisting the bar ends during the design process, it enables stable fixation without additional manipulation by the medical staff. According to a local representative, this is the industry's first product with such a structural distinction, and it attracted significant interest from the attending medical professionals.


During the event, Dr. John DiFiore delivered a lecture on the usage and surgical techniques of "Pectus," which was accompanied by hands-on anatomical training using the product. Last September, he visited L&K Biomed's Seoul headquarters and Yongin factory to discuss the development of new implants and instruments based on his clinical experience, continuing their collaborative relationship.


An L&K Biomed representative stated, "Securing major reference hospitals in the U.S. is a key foundation for expanding into the global market, and we plan to continue increasing clinical applications, especially at large medical institutions. We are focusing on providing solutions tailored to the local medical environment by strengthening training programs for medical professionals and improving product usability."



The representative added, "We will continue to expand our collaborative network with leading overseas hospitals and secure differentiated competitiveness in the global medical device market through ongoing product development and innovation."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing